A Clinical Study of Hyperthyroidism in Children

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 18, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Hyperthyroidism
Interventions
DRUG

Methimazole(MMI)

The initial dose of methimazole was 0.2-0.8 mg/(kg▪d). This dose was subsequently reduced by 25% to 50% and adjusted to maintain euthyroidism, based on the results of serum thyroid hormone testing during follow-up.

Trial Locations (1)

110004

RECRUITING

Shengjing Hospital of China Medical University, Shenyang

All Listed Sponsors
lead

Shengjing Hospital

OTHER